Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Hematology

Reducing the Iron Burden and Improving Survival in Transfusion-Dependent Thalassemia Patients: Current Perspectives [Corrigendum]

Journal of Blood Medicine

Hematology

2016

English

Clinical Outcomes and Diagnosis-To-Treatment Interval in Patients With Nk/T-Cell Lymphoma: 7-Year Follow-Up of the Nkea Study

Hematological Oncology

English

The Costs of Care in Haematological Cancers: Health Economic Issues

Hematological Oncology

English

The Braf Inhibitor Vemurafenib Plus Rituximab Produces a High Rate of Deep and Durable Responses in Relapsed/Refractory Hairy Cell Leukemia: Updated Results of a Phase-2 Trial

Hematological Oncology

English

The 23-Gene Gene Expression-Based Assay Does Not Predict Interim Pet Scan Results After Abvd in Advanced Stage Classical Hodgkin Lymphoma in the Us Intergroup S0816 Trial

Hematological Oncology

English

Response to A+chp by Cd30 Expression in the Echelon-2 Trial

Hematological Oncology

English

Dusp22 and Tp63 Rearrangements Predict Outcome of Alk-Negative Anaplastic Large Cell Lymphoma: A Danish Cohort Study

Hematological Oncology

English

Pd-1 Immune Checkpoint Blockade Improves Anti-Cd20 Based Immunotherapy in Follicular Lymphoma

Hematological Oncology

English

Phase Ii Study of Durvalumab (Anti-Pd-L1) Combined With Either R-Chop or Lenalidomide and R-Chop in Previously Untreated, High-Risk Diffuse Large B-Cell Lymphoma

Hematological Oncology

English

Bendamustine as Part of Conditioning Regimen for Autologous Stem-Cell Transplantation in Patients With Aggressive Lymphomas: Final Analysis of a Phase 2 Study From Geltamo

Hematological Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Hematology

Reducing the Iron Burden and Improving Survival in Transfusion-Dependent Thalassemia Patients: Current Perspectives [Corrigendum]

Clinical Outcomes and Diagnosis-To-Treatment Interval in Patients With Nk/T-Cell Lymphoma: 7-Year Follow-Up of the Nkea Study

The Costs of Care in Haematological Cancers: Health Economic Issues

The Braf Inhibitor Vemurafenib Plus Rituximab Produces a High Rate of Deep and Durable Responses in Relapsed/Refractory Hairy Cell Leukemia: Updated Results of a Phase-2 Trial

The 23-Gene Gene Expression-Based Assay Does Not Predict Interim Pet Scan Results After Abvd in Advanced Stage Classical Hodgkin Lymphoma in the Us Intergroup S0816 Trial

Response to A+chp by Cd30 Expression in the Echelon-2 Trial

Dusp22 and Tp63 Rearrangements Predict Outcome of Alk-Negative Anaplastic Large Cell Lymphoma: A Danish Cohort Study

Pd-1 Immune Checkpoint Blockade Improves Anti-Cd20 Based Immunotherapy in Follicular Lymphoma

Phase Ii Study of Durvalumab (Anti-Pd-L1) Combined With Either R-Chop or Lenalidomide and R-Chop in Previously Untreated, High-Risk Diffuse Large B-Cell Lymphoma

Bendamustine as Part of Conditioning Regimen for Autologous Stem-Cell Transplantation in Patients With Aggressive Lymphomas: Final Analysis of a Phase 2 Study From Geltamo